DA
AMGN icon

Dunvegan Associates’s Amgen AMGN Stock Holding History

Dunvegan Associates’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$6K Hold
40
– – 0.01% 176
2015
Q3 		$6K Hold
40
– – 0.01% 176
2015
Q2 		$6K Hold
40
– – 0.01% 180
2015
Q1 		$6K Hold
40
– – 0.01% 189
2014
Q4 		$6K Hold
40
– – 0.01% 185
2014
Q3 		$6K Hold
40
– – 0.01% 176
2014
Q2 		$5K Hold
40
– – ﹤0.01% 182
2014
Q1 		$5K Buy
+40
New +$4.85K ﹤0.01% 195

Other funds holding AMGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Dunvegan Associates's AMGN Position: Q4 2015 in Review

Dunvegan Associates held its Amgen (AMGN) position steady in Q4 2015 at 40 shares worth $6K. The position accounts for 0.01% of the portfolio, ranked #176.

Dunvegan Associates first reported a position in AMGN in Q1 2014 and has held it in 8 quarters since. 1,455 funds tracked by Wall St. Rank hold AMGN as of Q4 2015.

  • Dunvegan Associates held 40 shares of Amgen worth $6K as of Q4 2015.
  • Dunvegan Associates left its Amgen share count unchanged in Q4 2015.
  • Amgen made up 0.01% of Dunvegan Associates's portfolio in Q4 2015, its #176 holding.
  • Dunvegan Associates first reported a position in Amgen in Q1 2014 and has held it in 8 quarters since.
  • 1,455 funds tracked by Wall St. Rank held Amgen as of Q4 2015.

Based on Dunvegan Associates's 13F filing for Q4 2015, filed 28 Apr 2017.